SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VINCENZI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.130
EU - Europa 3.239
AS - Asia 2.915
SA - Sud America 376
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 5
Totale 16.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.066
SG - Singapore 1.231
CN - Cina 1.023
IT - Italia 910
UA - Ucraina 527
DE - Germania 509
TR - Turchia 387
PL - Polonia 339
BR - Brasile 338
GB - Regno Unito 287
FI - Finlandia 195
SE - Svezia 166
ID - Indonesia 101
FR - Francia 63
CA - Canada 50
HK - Hong Kong 49
BE - Belgio 46
RU - Federazione Russa 40
NL - Olanda 37
VN - Vietnam 33
CZ - Repubblica Ceca 27
AT - Austria 20
CH - Svizzera 17
ZA - Sudafrica 17
LT - Lituania 15
BD - Bangladesh 12
PK - Pakistan 10
IE - Irlanda 9
UZ - Uzbekistan 9
CL - Cile 8
EC - Ecuador 8
EU - Europa 8
IN - India 8
JP - Giappone 8
IQ - Iraq 7
AR - Argentina 6
CO - Colombia 6
PT - Portogallo 6
AU - Australia 5
TN - Tunisia 5
AL - Albania 4
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
KR - Corea 4
MA - Marocco 4
MX - Messico 4
RO - Romania 4
BG - Bulgaria 3
EG - Egitto 3
JO - Giordania 3
LV - Lettonia 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CG - Congo 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 16.713
Salva come PNG Salva come JPEG
Città #
Fairfield 1.187
Woodbridge 1.155
Chandler 795
Ann Arbor 709
Houston 706
Ashburn 648
Jacksonville 615
Singapore 580
Santa Clara 571
Seattle 488
Wilmington 469
Cambridge 421
Ferrara 350
Warsaw 336
Izmir 234
Beijing 232
Nanjing 168
Princeton 163
Shanghai 131
Milan 113
Boardman 111
San Diego 105
Jakarta 100
Los Angeles 93
Helsinki 75
New York 59
Bremen 57
Nanchang 52
Shenyang 49
Hong Kong 48
Dearborn 47
Tianjin 45
Brussels 44
Bologna 43
London 42
Hebei 36
Jiaxing 35
Falls Church 34
Toronto 32
Changsha 28
Munich 28
São Paulo 27
Frankfurt am Main 26
Auburn Hills 24
Brno 23
Norwalk 23
Zhengzhou 23
Dong Ket 22
Falkenstein 21
Mountain View 21
Council Bluffs 20
Nuremberg 20
Washington 20
The Dalles 19
Guangzhou 17
Kunming 17
Des Moines 16
Jinan 16
Orange 16
Zurich 16
Addison 14
Ferrara di Monte Baldo 14
Ottawa 14
Redwood City 14
San Mateo 13
Ningbo 12
Tappahannock 12
Verona 12
Rome 11
Augusta 10
Curitiba 10
Rio de Janeiro 10
Venice 10
Belo Horizonte 9
Indiana 8
Lauterbourg 8
Nice 8
Brasília 7
Chicago 7
Espoo 7
Ipswich 7
Istanbul 7
Kilburn 7
Tashkent 7
Tokyo 7
Vienna 7
Dublin 6
Florence 6
Hangzhou 6
Modena 6
Montebelluna 6
Salvador 6
San Francisco 6
Aversa 5
Chattanooga 5
Dhaka 5
Haikou 5
Hefei 5
Ho Chi Minh City 5
Las Vegas 5
Totale 11.950
Salva come PNG Salva come JPEG
Nome #
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 269
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 208
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 193
Pharmacology of Adenosine Receptors: The State of the Art 187
ALTERED EXPRESSION AND FUNCTIONALITY OF A2A ADENOSINE RECEPTORS IN HUNTINGTON’S DISEASE AND OTHER POLYGLUTAMINE DISORDERS 181
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 179
The A3 adenosine receptor: history and perspectives 179
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 176
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 167
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 162
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 162
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 157
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 155
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 154
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 154
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 153
Pathological overproduction: the bad side of adenosine 153
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 151
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 149
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 148
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 148
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 147
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 145
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 145
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 145
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 144
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 140
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 139
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 136
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 136
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 136
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 134
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 133
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 130
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 130
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 129
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 129
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 126
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 125
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 124
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 124
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 124
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 124
null 121
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 120
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 120
The role of adenosine receptors in rheumatoid arthritis. 119
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 118
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 118
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 118
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 117
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes 116
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 116
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes 116
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 115
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study 114
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 114
Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain 114
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 112
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 111
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 109
null 107
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 107
null 106
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 104
null 104
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 103
Targeting A3 and A2A adenosine receptors in the fight against cancer 103
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 102
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 102
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 101
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 100
Anxiolytic properties of A1 adenosine receptor PAMs 98
Development of novel pyridazinone-based adenosine receptor ligands 98
Effects of pulsed electromagnetic field exposure and adenosine analogues on prostaglandin release in bovine synovial fibroblasts. 97
Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes 97
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 97
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 97
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 96
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 95
null 94
null 93
null 92
null 91
null 91
Effect of Pulsed Electromagnetic Field Exposure on Adenosine Receptors in Human Fibroblast-like Synoviocytes 89
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 89
null 88
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 88
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 88
NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice 87
null 86
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 86
Effects of pulsed electromagnetic field exposure on adenosine receptors in human fibroblast-like synoviocytes. 85
A2A adenosine receptors and chronic caffeine intake in human neutrophils 85
ST 1535: A preferential A2A adenosine receptor antagonist 84
null 84
null 83
null 83
null 83
Totale 12.281
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.614
Totale 91.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020503 0 0 0 0 0 0 0 0 0 295 152 56
2020/20212.582 147 157 105 260 194 254 186 321 111 423 289 135
2021/20221.497 46 155 119 34 50 82 101 97 63 128 237 385
2022/20231.779 176 190 47 259 260 220 122 143 192 18 85 67
2023/20241.078 88 111 51 33 106 137 66 116 19 41 38 272
2024/20253.569 109 151 374 288 469 510 241 284 803 340 0 0
Totale 17.114